Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Akinsola, Adebayo K ^a   Ota, Martin O C ^a   Enwere, Godwin C ^a   Okoko, Brown J ^a   Zaman, Syed M A ^a,c   Saaka, Mark ^a   Nsekpong, Ekpedeme D ^a   Odutola, Aderonke A ^a   Greenwood, Brian M ^b   Cutts, Felicity T ^b   Adegbola, Richard A ^a,d  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; FOLLOW UP; GAMBIA; HUMAN; IMMUNIZATION; NASOPHARYNX; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TREATMENT RESPONSE; ANTIBODY PRODUCTION; HETEROZYGOTE; IMMUNOLOGY; INFANT; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CARRIER STATE; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; INFANT; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84857424055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031050     Document Type: Article

References (32)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
2. Goetghebuer T, West TE, Wemenbol V, Cadbury AL, Milligan P, et al. (2000) Outcome of meningitis caused by Streptococcus pneumoniae and Heamophilus influenzae type b in children in The Gambia. Trop Med Int Health 5: 207-213.
3. Adegbola RA, Falade AG, Sam BE, Hazlet D, Baldeh I, et al. (1994) The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J 13: 975-982.
4. O'Dempsey TJ, McArdle TF, Lloyd-Evans N, Baldeh I, Lawrence BE, et al. (1996) Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 15: 431-437.
5. Usen S, Adegbola R, Mulholland K, Jaffar S, Hilton S, et al. (1998) Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia. Pediatr Infect Dis J 17: 23-28.
6. Palmer A, Weber M, Bojang K, McKay T, Adegbola R, (1999) Acute bacterial meningitis in The Gambia: a four-year review of paediatric hospital admissions. J Trop Pediatr 45: 51-53.
7. Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, et al. (2006) Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 11: 1128-1135.
8. Mulholland EK, Ogunlesi OO, Adegbola RA, Weber M, Sam BE, et al. (1999) Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J 18 (Suppl 10): S35-S41.
9. Klugman K, Madhi S, Huebner R, Kohberger R, Mbelle N, (2003) A trial of a 9 valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349: 1341-1348.
10. Whitney CG, Farley MM, Hadler J, Harrison LE, Bennett NM, et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348: 1737-1746.
11. Saaka M, Okoko B, Kohberger R, Jaffar S, Enwere G, et al. (2008) Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine 26: 3719-3726.
12. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139-1146.
13. Heath PT, McVernon J, (2002) The UK Hib vaccine experience. Arch Dis Child 86: 396-399.
14. Obaro SK, Adegbola RA, Banya WA, Greenwood BM, (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348: 271-272.
15. Centers for Disease Control and Prevention (2010) Preventing pneumococcal disease among infants and young children: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 59 (RR-11): 1-18.
16. Brueggermann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432.
17. Obaro SK, Adegbola RA, Chang I, Banya WA, Jaffar S, et al. (2000) Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis J 19: 463-469.
18. Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, et al. (2007) Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 25: 3816-3826.
19. Aickin M, Gensler H, (1996) Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 86: 726-728.
20. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, et al. (1999) Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180: 1171-1176.
21. Miernyk K, Parkinson A, Rudolph K, Petersen KM, Bulkow LR, et al. (2000) Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and nonnative American children aged <2years. Clin Infect Dis 31: 34-41.
22. Weinberger DM, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, et al. (2008) Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis 197: 1511-1518.
23. Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, et al. (2009) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J 28: 990-995.
24. Hill PC, Cheung YB, Akisanya A, Sankareh K, Lahai G, et al. (2008) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis 46: 807-814.
25. Madhi S, Adrian P, Kuwanda L, Jassat W, Jones S, et al. (2007) Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 25: 2451-2457.
26. Ota MO, Akinsola A, Townend J, Antonio M, Enwere G, et al. (2011) The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule. Vaccine 29: 2999-3007.
27. World Health Organization (2007) Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Weekly Epidemiological Record 82: 93-104.
28. Trotter CL, McVernon J, Ramsay ME, Whitney CG, Mulholland EK, et al. (2008) Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 26: 4434-4445.
29. Russel FM, Carapetis JR, Satzke C, Tikoduadua L, Waqatakirewa L, et al. (2010) Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster. Clin Vaccine Immunol 12: 1970-1976.
30. Dagan R, Givon-Lavi N, Fraser D, Lipsitch M, Siber GR, et al. (2005) Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis 192: 367-376.
31. Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, et al. (2005) Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis 192: 387-393.
32. Hill PC, Akisanya A, Sankareh K, Cheung YB, Saaka M, et al. (2006) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 43: 673-679.